Interaction between complement subcomponent C1q and bacterial lipopolysaccharides
- PMID: 2649081
- PMCID: PMC1135668
- DOI: 10.1042/bj2570865
Interaction between complement subcomponent C1q and bacterial lipopolysaccharides
Abstract
The heptose-less mutant of Escherichia coli, D31m4, bound complement subcomponent C1q and its collagen-like fragments (C1qCLF) with Ka values of 1.4 x 10(8) and 2.0 x 10(8) M-1 respectively. This binding was suppressed by chemical modification of C1q and C1qCLF using diethyl pyrocarbonate (DEPC). To investigate the role of lipopolysaccharides (LPS) in this binding, biosynthetically labelled [14C]LPS were purified from E. coli D31m4 and incorporated into liposomes prepared from phosphatidylcholine (PC) and phosphatidylethanolamine (PE) [PC/PE/LPS, 2:2:1, by wt.]. Binding of C1q or its collagen-like fragments to the liposomes was estimated via a flotation test. These liposomes bound C1q and C1qCLF with Ka values of 8.0 x 10(7) and 2.0 x 10(7) M-1; this binding was totally inhibited after chemical modification of C1q and C1qCLF by DEPC. Liposomes containing LPS purified from the wild-strain E. coli K-12 S also bound C1q and C1qCLF, whereas direct binding of C1q or C1qCLF to the bacteria was negligible. Diamines at concentrations which dissociate C1 into C1q and (C1r, C1s)2, strongly inhibited the interaction of C1q or C1qCLF with LPS. Removal of 3-deoxy-D-manno-octulosonic acid (2-keto-3-deoxyoctonic acid; KDO) from E. coli D31m4 LPS decreases the binding of C1qCLF to the bacteria by 65%. When this purified and modified LPS was incorporated into liposomes, the C1qCLF binding was completely abolished. These results show: (i) the essential role of the collagen-like moiety and probably its histidine residues in the interaction between C1q and the mutant D31m4; (ii) the contribution of LPS, particularly the anionic charges of KDO, to this interaction.
Similar articles
-
Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.Biochem J. 1985 Dec 1;232(2):513-9. doi: 10.1042/bj2320513. Biochem J. 1985. PMID: 3911948 Free PMC article.
-
Antibody-independent C1 activation by E. coli.J Immunol. 1984 Aug;133(2):886-91. J Immunol. 1984. PMID: 6376630
-
Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.Infect Immun. 1981 Mar;31(3):1138-44. doi: 10.1128/iai.31.3.1138-1144.1981. Infect Immun. 1981. PMID: 6971812 Free PMC article.
-
Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.Behring Inst Mitt. 1989 Jul;(84):236-54. Behring Inst Mitt. 1989. PMID: 2552981 Review.
-
C1 subcomponent complexes: basic and clinical aspects.Behring Inst Mitt. 1993 Dec;(93):292-8. Behring Inst Mitt. 1993. PMID: 8172579 Review.
Cited by
-
Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.J Exp Med. 1992 May 1;175(5):1373-9. doi: 10.1084/jem.175.5.1373. J Exp Med. 1992. PMID: 1569403 Free PMC article.
-
Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.Protein Cell. 2011 Apr;2(4):320-32. doi: 10.1007/s13238-011-1029-y. Epub 2011 May 15. Protein Cell. 2011. PMID: 21574022 Free PMC article.
-
Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36.Infect Immun. 1996 Nov;64(11):4719-25. doi: 10.1128/iai.64.11.4719-4725.1996. Infect Immun. 1996. PMID: 8890231 Free PMC article.
-
Chemical characterization and location of ionic interactions involved in the assembly of the C1 complex of human complement.J Protein Chem. 1993 Dec;12(6):771-81. doi: 10.1007/BF01024936. J Protein Chem. 1993. PMID: 8136028
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous